spike protein

Open Access
Seroepidemiological Observational Study in Total and Neutralizing Antibodies to SARS-CoV-2 Among Primary Care Patients in Crete, Greece
ZOI POURNARA, EMMANOUELA KISSANDRAKI, SEVASTI KOURSIOTI, MANOLIS LINARDAKIS, EMMANOUIL K. SYMVOULAKIS, MARILENNA ANASTASAKI, CHRISTOS D. LIONIS and GEORGE SOURVINOS

In Vivo March 2026, 40 (2) 1207-1219; DOI: https://doi.org/10.21873/invivo.14276
Open Access
SARS-CoV-2 Spike Protein Induces Oxidative Stress and Senescence in Mouse and Human Lung
JOEL S. GREENBERGER, WEN HOU, DONNA SHIELDS, RENEE FISHER, MICHAEL W. EPPERLY, INDERPAL SARKARIA, PETER WIPF and HONG WANG

In Vivo July 2024, 38 (4) 1546-1556; DOI: https://doi.org/10.21873/invivo.13605
Open Access
Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens
PATRICK MORHART, SVEN KEHL, WOLFGANG SCHUH, KATHARINA HERMES, STEFAN MELTENDORF, ANTJE NEUBERT, MICHAEL SCHNEIDER, MONIKA BRUNNER-WEINZIERL, HOLM SCHNEIDER and HOLGER LINGEL

In Vivo January 2023, 37 (1) 70-78; DOI: https://doi.org/10.21873/invivo.13055
You have access
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
STEVEN LEHRER and PETER H. RHEINSTEIN

In Vivo September 2020, 34 (5) 3023-3026; DOI: https://doi.org/10.21873/invivo.12134

Main menu